Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Artificial Intelligence in Accelerating Drug Discovery and Development
Anushree Tripathi, Krishna Misra, Richa Dhanuka, et al.
Recent Patents on Biotechnology (2022) Vol. 17, Iss. 1, pp. 9-23
Closed Access | Times Cited: 22

Showing 22 citing articles:

Organ-on-a-chip meets artificial intelligence in drug evaluation
Shiwen Deng, Caifeng Li, Junxian Cao, et al.
Theranostics (2023) Vol. 13, Iss. 13, pp. 4526-4558
Open Access | Times Cited: 53
Explainable Artificial Intelligence for Drug Discovery and Development: A Comprehensive Survey
Roohallah Alizadehsani, Solomon Sunday Oyelere, Sadiq Hussain, et al.
IEEE Access (2024) Vol. 12, pp. 35796-35812
Open Access | Times Cited: 23
Evolution of artificial intelligence in healthcare: a 30-year bibliometric study
Yiweng Xie, Yuansheng Zhai, Guihua Lu
Frontiers in Medicine (2025) Vol. 11
Open Access | Times Cited: 3
The Role of AI in Drug Discovery
M.K.G. Abbas, Abrar Rassam, Fatima Karamshahi, et al.
ChemBioChem (2024) Vol. 25, Iss. 14
Open Access | Times Cited: 11
Application of artificial intelligence to the public health education
Xueyan Wang, Xiujing He, Jiawei Wei, et al.
Frontiers in Public Health (2023) Vol. 10
Open Access | Times Cited: 19
The real-world impact of National Institute for Health and Care Excellence's real-world evidence framework
Stephen Duffield, Páll Jónsson
Journal of Comparative Effectiveness Research (2023) Vol. 12, Iss. 11
Open Access | Times Cited: 19
Artificial intelligence in drug discovery and development
Abdülhamit Subaşı
Elsevier eBooks (2024), pp. 417-454
Closed Access | Times Cited: 6
Evaluating the effect of artificial intelligence on pharmaceutical product and drug discovery in China
Agyemang Kwasi Sampene, Fatuma Nyirenda
Future Journal of Pharmaceutical Sciences (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 5
Revolutionizing Biological Science: The Synergy of Genomics in Health, Bioinformatics, Agriculture, and Artificial Intelligence
Aakanksha Biswas, Aditi Kumari, D. S. Gaikwad, et al.
OMICS A Journal of Integrative Biology (2023) Vol. 27, Iss. 12, pp. 550-569
Closed Access | Times Cited: 11
Intelligent Processing of Design Notices in Engineering Procurement Construction Projects
Zhiqi Chen, Ling Zhang, Xing Su
Buildings (2025) Vol. 15, Iss. 5, pp. 805-805
Open Access
Machine Learning-Based Virtual Screening and Molecular Modeling Reveal Potential Natural Inhibitors for Non-Small Cell Lung Cancer
Zafer Saad Al Shehri, Faez Falah Alshehri
Crystals (2025) Vol. 15, Iss. 5, pp. 383-383
Open Access
Accelerating Precision Medicine Through Advanced Computational Techniques
B. M. Parashiva Murthy, Saba Fatima, Harishchander Anandaram, et al.
Advances in computational intelligence and robotics book series (2025), pp. 307-330
Closed Access
Perspectives, Challenges, and the Future of Biomedical Technology and Artificial Intelligence
Saúl Tovar‐Arriaga, Gerardo I. Pérez‐Soto, Karla A. Camarillo‐Gómez, et al.
Technologies (2024) Vol. 12, Iss. 11, pp. 212-212
Open Access | Times Cited: 2
Applications of Deep Learning for Drug Discovery Systems with BigData
Yasunari Matsuzaka, Ryu Yashiro
BioMedInformatics (2022) Vol. 2, Iss. 4, pp. 603-624
Open Access | Times Cited: 11
Artificial intelligence and machine learning responses to COVID-19 related inquiries
Naser Zaeri
Journal of Medical Engineering & Technology (2023) Vol. 47, Iss. 6, pp. 301-320
Closed Access | Times Cited: 4
Integrative Machine Learning, Virtual Screening, and Molecular Modeling for BacA-Targeted Anti-Biofilm Drug Discovery Against Staphylococcal Infections
Ahmad Almatroudi
Crystals (2024) Vol. 14, Iss. 12, pp. 1057-1057
Open Access | Times Cited: 1
A combination of structure-based virtual screening and experimental strategies to identify the potency of caffeic acid ester derivatives as SARS-CoV-2 3CLpro inhibitor from an in-house database
Piyatida Pojtanadithee, Kulpornsorn Isswanich, Koonchira Buaban, et al.
Biophysical Chemistry (2023) Vol. 304, pp. 107125-107125
Open Access | Times Cited: 3
Biotechnological Drug Development—The Role of Proteins, Genes, In-Silico, and Stem Cells in Designing Models for Enhanced Drug Discovery
Taofik Ahmed Suleiman, Ann Christopher Francis, Abdulwasiu Ibrahim, et al.
OALib (2023) Vol. 10, Iss. 08, pp. 1-20
Open Access | Times Cited: 2
Public Health, Public Health Education, and their Future Prospects

Frontiers research topics (2024)
Open Access
Application of Virtual Drug Study to New Drug Research and Development: Challenges and Opportunity
Xiuqi Li, Shupeng Liu, Dan Liu, et al.
Clinical Pharmacokinetics (2024) Vol. 63, Iss. 9, pp. 1239-1249
Closed Access
A meta-analysis of AI and machine learning in project management: Optimizing vaccine development for emerging viral threats in biotechnology
Jatin Vaghasiya, Muhammad Zargham Khan, Tarak Milan Bakhda
International Journal of Medical Informatics (2024) Vol. 195, pp. 105768-105768
Closed Access
A Combination of Structure-based Virtual Screening and Experimental Strategies to Identify the Potency of Caffeic Acid Ester Derivatives as SARS-CoV-2 3CLpro Inhibitor from an In-house Database
Piyatida Pojtanadithee, Kulpornsorn Isswanich, Koonchira Buaban, et al.
Research Square (Research Square) (2023)
Open Access
Page 1

Scroll to top